Search Results 321-330 of 15055 for TNF

  1. Running Archives - Mayo Clinic News Network

  2. Orhun H. Kantarci, M.D. - Mayo Clinic Faculty Profiles

    " They also have published the first open-label trial of using TNF-alpha inhibitors to successfully arrest Neuro-Behcet syndrome when other strategies fail for ...

  3. Coronavirus Disease 2019 Clinical Trials - Mayo Clinic Research

    Hypothesis: Baseline cytokine (IL-1β, IL-6, IL-4, IL-10, IFN-g and TNF-a) and the immune cellular repertoire (helper/CD4+, cytotoxic/CD8+, T-regulatory ...

  4. Optimization of Performance and Health Program - Human Integrative and Environmental Physiology Lab: Bruce D. Johnson - Mayo Clinic Research

    In 2012, Mayo Clinic, The North Face and National Geographic collaborated to carry out a scientific expedition to Mount Everest. The major aim was to ...

  5. Neurology - Clinical trials - Mayo Clinic

    The purpose of this study is to determine the prevalence, diagnostic accuracy and predictors of antinueronal antibody positivity in serum and cerebrospinal ...

  6. Infectious Diseases! Clinical Trials - Mayo Clinic Research

    Hypothesis: Baseline cytokine (IL-1β, IL-6, IL-4, IL-10, IFN-g and TNF-a) and the immune cellular repertoire (helper/CD4+, cytotoxic/CD8+, T-regulatory ...

  7. A Study to Evaluate the Safety and Effectiveness of BMS-986036 (pegbelfermin) in Adults with Nonalcoholic Steatophepatitis (NASH) and Compensated Liver Fibrosis - Mayo Clinic

    About this study. The purpose of this study is to confirm and extend the results observed in the Phase 1 and 2a studies with BMS-986036.

  8. Malignant peripheral nerve sheath tumors (MPNST) - Doctors and departments - Mayo Clinic

    These cancers form in the linings of nerves. Treatment includes surgery, radiation therapy and, sometimes, chemotherapy.

  9. A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy - Mayo Clinic

    ... tumor necrosis factor agents) within 2 weeks prior to initiation of study treatment or anticipated need for systemic immunosuppressive medications during ...

  10. A Study to Assess Subcutaneous Lirentelimab (AK002) in Chronic Spontaneous Urticaria - Mayo Clinic

    mycophenolate mofetil), alkylating agents (e.g., cyclophosphamide), TNF inhibitors (e.g., infliximab, adalimumab), and eosinophil-depleting drugs (e.g. ...